Map kinase pathways activated by stress: The p38 MAPK pathway

Critical Care Medicine

Volumn 28, Issue 4 SUPPL., 2000, Pages

  Obata, Toshiyuki ^a   Brown, Glenn E ^a,b   Yaffe, Michael B ^a,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Apoptosis; JNK; p38 MAP kinase; Stress; Transcription

Indexed keywords

CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGENIC AGENT; STRESS ACTIVATED PROTEIN KINASE;

ALZHEIMER DISEASE; APOPTOSIS; CRITICAL ILLNESS; CYTOKINE PRODUCTION; CYTOSKELETON; ENZYME ACTIVATION; HEAT SHOCK; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRRADIATION; ISCHEMIC HEART DISEASE; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION REGULATION; ULTRAVIOLET RADIATION;

EID: 0034097798     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200004001-00008     Document Type: Review

References (174)

1. Cobb MH, Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 1995; 270: 14843-14846
2. Hunter T: Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 1995; 80: 225-236
3. Han J, Lee JD, Bibbs L, et al: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265: 808-811
4. Lee JC, Laydon JT, McDonnell PC, et al: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739-746
5. Rouse J, Cohen P, Trigon S, et al: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994; 78:1027-1037
6. Wang XS, Diener K, Manthey CL, et al: Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem 1997; 272:23668-23674
7. Derijard B, Hibi M, Wu IH, et al: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-1037
8. Kyriakis JM, Banerjee P, Nikolakaki E, et al: The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156-160
9. Gupta S, Barrett T, Whitmarsh AJ, et al: Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996; 15:2760-2770
10. Gould GW, Cuenda A, Thomson FJ, et al: The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells. Biochem J 1995; 311:735-738
11. Yuasa T, Ohno S, Kehrl JH, et al: Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J Biol Chem 1998; 273:22681-22692
12. Mikkola I, Bruun JA, Bjorkoy G, et al: Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase. J Biol Chem 1999; 274:15115-15126
13. Ganiatsas S, Kwee L, Fujiwara Y, et al: SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc Natl Acad Sci U S A 1998; 95:6881-6886
14. Nishina H, Vaz C, Billia P, et al: Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development 1999; 126: 505-516
15. Brewster JL, de Valoir T, Dwyer ND, et al: An osmosensing signal transduction pathway in yeast. Science 1993; 259:1760-1763
16. Raingeaud J, Gupta S, Rogers JS, et al: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270:7420-7426
17. Jiang Y, Gram H, Zhao M, et al: Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem 1996; 271: 17920-17926
18. Freshney NW, Rawlinson L, Guesdon F, et al: Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994; 78:1039-1049
19. Li Z, Jiang Y, Ulevitch RJ, Han J: The primary structure of p38 gamma: A new member of p38 group of MAP kinases. Biochem Biophys Res Commun 1996; 228:334-340
20. Stein B, Yang MX, Young DB, et al: p38-2, a novel mitogen-activated protein kinase with distinct properties. J Biol Chem 1997; 272:19509-19517
21. Enslen H, Raingeaud J, Davis RJ: Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 1998; 273:1741-1748
22. Hu MC, Wang YP, Mikhail A, et al: Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines. J Biol Chem 1999; 274: 7095-7102
23. Lechner C, Zahalka MA, Giot JF, et al: ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci U S A 1996; 93: 4355-4359
24. Hale KK, Trollinger D, Rihanek M, et al: Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J Immunol 1999; 162:4246-4252
25. Nick JA, Avdi NJ, Young SK, et al: Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 1999; 103:851-858
26. Yang SH, Galanis A, Sharrocks AD: Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. Mol Cell Biol 1999; 19:4028-4038
27. Hanks SK, Hunter T: Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 1995; 9:576-596
28. Raingeaud J, Whitmarsh AJ, Barrett T, et al: MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 1996; 16:1247-1255
29. Derijard B, Raingeaud J, Barrett T, et al: Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms [published erratum appears in Science 1995; 269:17]. Science 1995; 267:682-685
30. Lin A, Minden A, Hartinetto H, et al: Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 1995; 268:286-290
31. Blank JL, Gerwins P, Elliott EM, et al: Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. J Biol Chem 1996; 271:5361-5368
32. Deacon K, Blank JL: MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases. J Biol Chem 1999; 274: 16604-16610
33. Hirai S, Izawa M, Osada S, et al: Activation of the JNK pathway by distantly related protein kinases, MEKK and MUK. Oncogene 1996; 12:641-650
34. Takekawa M, Posas F, Saito H: A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways. EMBO J 1997; 16:4973-4982
35. Rana A, Gallo K, Godowski P, et al: The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J Biol Chem 1996; 271:19025-19028
36. Yamaguchi K, Shirakabe K, Shibuya H, et al: Identification of a member of the MAP-KKK family as a potential mediator of TGF-beta signal transduction. Science 1995; 270: 2008-2011
37. Salmeron A, Ahmad TB, Carlile GW, et al: Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J 1996; 15:817-826
38. Ichijo H, Nishida E, Irie K, et al: Induction of apoptosis by ASK1, a mammalian MAP-KKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275:90-94
39. Hutchison M, Berman KS, Cobb MH: Isolation of TA01, a protein kinase that activates MEKs in stress-activated protein kinase cascades. J Biol Chem 1998; 273:28625-28632
40. Guan Z, Buckman SY, Miller BW, et al: Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 1998; 273:28670-28676
41. Minden A, Lin A, Claret FX, et al: Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995; 81: 1147-1157
42. Bagrodia S, Derijard B, Davis RJ, et al: Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J Biol Chem 1995; 270:27995-27998
43. Zhang S, Han J, Sells MA, et al: Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 1995; 270: 23934-23936
44. Lim L, Manser E, Leung T, et al: Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways. Eur J Biochem 1996; 242:171-185
45. Wu C, Whiteway M, Thomas DY, et al: Molecular characterization of Ste20p, a potential mitogen-activated protein or extracellular signal-regulated kinase kinase (MEK) kinase kinase from Saccharomyces cerevisiae. J Biol Chem 1995; 27:15984-15992
46. Fanger GR, Johnson NL, Johnson GL: MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J 1997; 16: 4961-4972
47. Wesche H, Henzel WJ, Shillinglaw W, et al: MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997; 7: 837-847
48. Muzio M, Natoli C, Saccani S, et al: The human toll signaling pathway: Divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 1998; 187:2097-2101
49. Burns K, Martinon F, Esslinger C, et al: MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998; 273:12203-12209
50. Kawai T, Adachi O, Ogawa T, et al: Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11:115-122
51. Yang X, Khosravi-Far R, Chang HY, et al: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997; 89: 1067-1076
52. Chang HY, Nishitoh H, Yang X, et al: Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 1998; 281:1860-1863
53. Ishibashi T, Bottaro DP, Chan A, et al: Expression cloning of a human dual-specificity phosphatase. Proc Natl Acad Sci U S A 1992; 89:12170-12174
54. Keyse SM, Emslie EA: Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 1992; 359:644-647
55. Alessi DR, Smythe C, Keyse SM: The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogens 1993; 8:2015-2020
56. Sun H, Charles CH, Lau LF, et al: MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993; 75:487-493
57. Rohan PJ, Davis P, Moskaluk CA, et al: PAC-1: A mitogen-induced nuclear protein tyrosine phosphatase. Science 1993; 259: 1763-1766
58. Ward Y, Gupta S, Jensen P, et al: Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature 1994; 367:651-654
59. Guan KL, Butch E: Isolation and characterization of a novel dual specific phosphatase, HVH2, which selectively dephosphorylates the mitogen-activated protein kinase. J Biol Chem 1995; 270:7197-7203
60. Misra-Press A, Rim CS, Yao H, et al: A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation. J Biol Chem 1995; 270:14587-14596
61. King AG, Ozanne BW, Smythe C, et al: Isolation and characterisation of a uniquely regulated threonine, tyrosine phosphatase (TYP 1) which inactivates ERK2 and p54jnk. Oncogene 1995; 11:2553-2563
62. Kwak SP, Dixon JE: Multiple dual specificity protein tyrosine phosphatases are expressed and regulated differentially in liver cell lines. J Biol Chem 1995; 270:1156-1160
63. Ishibashi T, Bottaro DP, Michieli P, et al: A novel dual specificity phosphatase induced by serum stimulation and heat shock. J Biol Chem 1994; 269:29897-29902
64. Martell KJ, Seasholtz AF, Kwak SP, et al: hVH-5: a protein tyrosine phosphatase abundant in brain that inactivates mitogen-activated protein kinase. J Neurochem 1995; 65:1823-1833
65. Theodosiou AM, Rodrigues NR, Nesbit MA, et al: A member of the MAP kinase phosphatase gene family in mouse containing a complex trinucleotide repeat in the coding region. Hum Mol Genet 1996; 5:675-684
66. Muda M, Boschert U, Dickinson R, et al: MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J Biol Chem 1996; 271:4319-4326
67. Mourey RJ, Vega QC, Campbell JS, et al: A novel cytoplasmic dual specificity protein tyrosine phosphatase implicated in muscle and neuronal differentiation. J Biol Chem 1996; 271:3795-3802
68. Groom LA, Sneddon AA, Alessi DR, et al: Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J 1996; 15:3621-3632
69. Dowd S, Sneddon AA, Keyse SM: Isolation of the human genes encoding the pyst1 and Pyst2 phosphatases: characterisation of Pyst2 as a cytosolic dual-specificity MAP kinase phosphatase and its catalytic activation by both MAP and SAP kinases. J Cell Sci 1998; 111:3389-3399
70. Muda M, Boschert U, Smith A, et al: Molecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4. J Biol Chem 1997; 272:5141-5151
71. Tanoue T, Moriguchi T, Nishida E: Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J Biol Chem 1999; 274:19949-19956
72. Franklin CC, Srikanth S, Kraft AS: Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis. Proc Natl Acad Sci U S A 1998; 95: 3014-3019
73. Muda M, Theodosiou A, Rodrigues N, et al: The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 1996; 271: 27205-27208
74. Tong L, et al. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat Struct Biol 1997; 4:311-316
75. Wang Z, Harkins PC, Ulevitch RJ, et al: The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. Proc Natl Acad Sci U S A 1997; 94:2327-2332
76. Wang Z, Canagarajah BJ, Boehm JC, et al: Structural basis of inhibitor selectivity in MAP kinases. Structure 1998; 6:1117-1128
77. Wilson KP, Fitzgibbon MJ, Caron PR, et al: Crystal structure of p38 mitogen-activated protein kinase. J Biol Chem 1996; 271: 27696-27700
78. Wilson KP. McCaffrey PG, Hsiao K, et al: The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem Biol 1997; 4:423-431
79. Gavin AC, Nebreda AR: A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1. Curr Biol 1999; 9:281-284
80. Jacobs D, Glossip D, Xing H, et al: Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev 1999; 13: 163-175
81. Fox T, Coll JT, Xie X, et al: A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Protein Sci 1998; 7:2249-2255
82. Lisnock J, Tebben A, Frantz B, et al: Molecular basis for p38 protein kinase inhibitor specificity [published erratum appears in Biochemistry 1999; 38:3456]. Biochemistry 1998; 37:16573-16581
83. Maulik N, Yoshida T, Zu YL, et al: Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am J Physiol 1998; 275: H1857-H1864
84. Ben LR, Hooper S, Wilson R, et al: Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 1998; 8:1049-1057
85. Degols G, Russell P: Discrete roles of the Spc1 kinase and the Atf1 transcription factor in the UV response of Schizosaccharomyces pombe. Mol Cell Biol 1997; 17: 3356-3363
86. Wang XZ, Ron D: Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 1996; 272:1347-1349
87. Tanaka K, Oda N, Iwasaka C, et al: Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J Cell Physiol 1998; 176:235-244
88. Zervos AS, Faccio L, Gatto JP, et al: Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc Natl Acad Sci U S A 1995; 92: 10531-10534
89. Han J, Jiang Y, Li Z, et al: Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 1997; 386:296-299
90. Zechner D, Craig R, Hanford DS, et al: MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem 1998; 273:8232-8239
91. Kim J, Nueda A, Meng YH, et al: Analysis of the phosphorylation of human heat shock transcription factor-1 by MAP kinase family members. J Cell Biochem 1997; 67:43-54
92. Janknecht R, Hunter T: Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J 1997; 16: 1620-1627
93. Hsu SC, Gavrilin MA, Tsai MH, et al: p38 mitogen-activated protein kinase is involved in Fas ligand expression. J Biol Chem 1999; 274:25769-25776
94. Nadkarni V, Gabbay KH, Bohren KM, et al: Osmotic response element enhancer activity. Regulation through p38 kinase and mitogen-activated extracellular signal-regulated kinase kinase. J Biol Chem 1999; 274: 20185-20190
95. Sutherland C, Campbell DG, Cohen P: Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. Eur J Biochem 1993; 217:715-722
96. Thomas G, Haavik J, Cohen P: Participation of a stress-activated protein kinase cascade in the activation of tyrosine hydroxylase in chromaffin cells. Eur J Biochem 1997; 247: 1180-1189
97. Zaheer A, Lim R: Overexpression of glia maturation factor (GMF) in PC12 pheochromocytoma cells activates p38 MAP kinase, MAPKAP kinase-2, and tyrosine hydroxylase. Biochem Biophys Res Commun 1998; 250:278-282
98. Suzuki A, Palmer G, Bonjour JP, et al: Regulation of alkaline phosphatase activity by p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells. Endocrinology 1999; 140:3177-3182
99. 1-adrenergic receptor subtypes. J Neurochem 1999; 72:2388-2396
100. Moule SK, Denton RM: The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett 1998; 439:287-290
101. Waterman WH, Molski TF, Huang CK, et al: Tumour necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem J 1996; 319:17-20
102. Husain S, Abdel-Latif AA: Endothelin-1 activates p38 mitogen-activated protein kinase and cytosolic phospholipase A2 in cat iris sphincter smooth muscle cells [In Process Citation]. Biochem J 1999; 342:87-96
103. Hwang D, Jang BC, Yu G, et al: Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: Mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem Pharmacol 1997; 54:87-96
104. Pouliot M, Baillargeon J, Lee JC, et al: Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase. J Immunol 1997; 158:4930-4937
105. Ridley SH, Sarsfield SJ, Lee JC, et al: Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 1997; 158:3165-3173
106. Schafer PH, Wadsworth SA, Wang L, et al: p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45R0+ T cells and Th2 effector cells. J Immunol 1999; 162:7110-7119
107. Beyaert R, Cuenda A, Vanden Berghe W, et al: The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 1996; 15:1914-1923
108. Marie C, Roman-Roman S, Rawadi G: Involvement of mitogen-activated protein kinase pathways in interleukin-8 production by human monocytes and polymorphonuclear cells stimulated with lipopolysaccharide or Mycoplasma fermentans membrane lipoproteins. Infect Immun 1999; 67: 688-693
109. Lu HT, Yang DD, Wysk M, et al: Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J 1999; 18:1845-1857
110. Suzuki K, Hino M, Hato F, et al: Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. Blood 1999; 93:341-349
111. Hannigan M, Zhan L, Ai Y, et al: The role of p38 MAP kinase in TGF-betal-induced signal transduction in human neutrophils. Biochem Biophys Res Commun 1998; 246: 55-58
112. Yaffe MB, Xu J, Burke PA, et al: Priming of the neutrophil respiratory burst is species-dependent and involves MAP kinase activation. Surgery 1999; 126:248-254
113. Lal AS, Clifton AD, Rouse J, et al: Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/p38. Biochem Biophys Res Commun 1999; 259:465-470
114. Caivano M: Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett 1998; 429:249-253
115. 2 biosynthesis stimulated by interleukin-1beta. J Biol Chem 1997; 272:8083-8089
116. Browning DD, Windes ND, Ye RD: Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation. J Biol Chem 1999; 274:537-542
117. Jun CD, Oh CD, Kwak HJ, et al: Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. J Immunol 1999; 162:3395-3401
118. Hedges JC, Dechert MA, Yamboliev IA, et al: A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J Biol Chem 1999; 274:24211-24219
119. Rousseau S, Houle F, Landry J, et al: p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogens 1997; 15:2169-2177
120. Goedert M, Hasegawa M, Jakes R, et al: Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 1997; 409:57-62
121. Hedges JC, Yamboliev IA, Ngo M, et al: p38 mitogen-activated protein kinase expression and activation in smooth muscle. Am J Physiol 1998; 275:C527-C534
122. Cheng TJ, Lai YK: Identification of mitogen-activated protein kinase-activated protein kinase-2 as a vimentin kinase activated by okadaic acid in 9L rat brain tumor cells. J Cell Biochem 1998; 71:169-181
123. Feng L, Zhou X, Liao J, et al: Pervanadate-mediated tyrosine phosphorylation of keratins 8 and 19 via a p38 mitogen-activated protein kinase-dependent pathway. J Cell Sci 1999; 112:2081-2090
124. Landry J, Huot J: Modulation of actin dynamics during stress and physiological stimulation by a signaling pathway involving p38 MAP kinase and heat-shock protein 27. Biochem Cell Biol 1995; 73:703-717
125. Lavoie JN, Gingras-Breton G, Tanguay RM, et al: Induction of Chinese hamster HSP27 gene expression in mouse cells confers resistance to heat shock. HSP27 stabilization of the microfilament organization. J Biol Chem 1993; 268:3420-3429
126. Huang S, Jiang Y, Li Z, et al: Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity 1997; 6:739-749
127. Johnson NL, Gardner AM, Diener KM, et al: Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem 1996; 271: 3229-3237
128. Assefa Z, Vantiegham A, Declercq W, et al: The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J Biol Chem 1999; 274:8788-8796
129. Xia Z, Dickens M, Raingeaud J, et al: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331
130. Nagata Y, Todokoro K: Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 1999; 94:853-863
131. Roulston A, Reinhard C, Amiri P, et al: Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 1998; 273:10232-10239
132. Lee RJ, Albanese C, Stenger RJ, et al: pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J Biol Chem 1999; 274:7341-7350
133. Tamura DY, Moore EE, Johnson JL, et al: p38 mitogen-activated protein kinase inhibition attenuates intercellular adhesion molecule-1 up-regulation on human pulmonary microvascular endothelial cells. Surgery 1998; 124:403-407; discussion 408
134. Schnyder B, Meunier PC, Car BD: Inhibition of kinases impairs neutrophil activation and killing of Staphylococcus aureus. Biochem J 1998; 331:489-495
135. Rizoli SB, Rotstein O, Kapus A: Cell volume-dependent regulation of L-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase. J Biol Chem 1999; 274:22072-22080
136. Heuertz RM, Tricomi SM, Ezekiel UR, et al: C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement. J Biol Chem 1999; 274: 17968-17974
137. Zu YL, Qi J, Gilchrist A, et al: p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. J Immunol 1998; 160:1982-1989
138. Terada LS, Johansen KA, Nowbar S, et al: Pseudomonas aeruginosa hemolytic phospholipase C suppresses neutrophil respiratory burst activity. Infect Immun 1999; 67: 2371-2376
139. Rane MJ, Carrithers SL, Arthur JM, et al: Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: Role in activation of reduced nicotinamide adenine dinucleotide oxidase. J Immunol 1997; 159:5070-5078
140. Nick JA, Avdi NJ, Young SK, et al: Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest 1997; 99:975-986
141. McLeish KR, Klein JB, Coxon PY, et al: Bacterial phagocytosis activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in human neutrophils. J Leukoc Biol 1998; 64: 835-844
142. Das DK, Maulik N, Sato M, et al: Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol Cell Biochem 1999; 196:59-67
143. Ma XL, Kumar S, Gao F, et al: Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999; 99:1685-1691
144. Mackay K, Mochly-Rosen D: An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem 1999; 274:6272-6279
145. Wang Y, Huang S, Sah VP, et al: Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998; 273:2161-2168
146. Wang Y, Su B, Sah VP, et al: Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem 1998; 273: 5423-5426
147. Alpert D, Schwenger P, Han J, et al: Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation. J Biol Chem 1999; 274:22176-22183
148. Rawadi G, Ramez V, Lemercier B, et al: Activation of mitogen-activated protein kinase pathways by Mycoplasma fermentans membrane lipoproteins in murine macrophages: Involvement in cytokine synthesis. J Immunol 1998; 160:1330-1339
149. Rawadi G, Garcia J, Lemercier B, et al: Signal transduction pathways involved in the activation of NF-kappa B, AP-1, and c-fos by Mycoplasma fermentons membrane lipoproteins in macrophages. J Immunol 1999; 162:2193-21203
150. Garcia J, Lemercier B, Roman-Roman S, et al: A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-kappaB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways. J Biol Chem 1998; 273:34391-34398
151. Pyo H, Jou I, Jung S, et al: Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport 1998; 9:871-874
152. Palmer LE, Pancetti AR, Greenberg S, et al: YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells. Infect Immun 1999; 67:708-716
153. Ruckdeschel K, Machold J, Roggenkamp A, et al: Yersinia enterocolitica promotes deactivation of macrophage mitogen-activated protein kinases extracellular signal-regulated kinase-1/2, p38, and c-Jun NH2-terminal kinase. Correlation with its inhibitory effect on tumor necrosis factor-alpha production. J Biol Chem 1997; 272: 15920-15927
154. Yurochko AD, Huang ES: Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J Immunol 1999; 162:4806-4816
155. Johnson RA, Huong SM, Huang ES: Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole on HCMV DNA replication and permissive infection. Antiviral Res 1999; 41: 101-111
156. Bruening W, Giasson B, Mushynski W, et al: Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate/early promoter. Nucleic Acids Res 1998; 26:486-489
157. Cohen PS, Schmidtmayerova H, Dennis J, et al: The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol Med 1997; 3:339-346
158. Kumar S, Orsini MJ, Lee JC, et al: Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase. J Biol Chem 1996; 271:30864-30869
159. Kaul M, Lipton SA: Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 1999; 96:8212-8216
160. Nakahara S, Yone K, Sakou T, et al: Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: Possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis. J Neuropathol Exp Neurol 1999; 58:442-450
161. Hensley K, Floyd RA, Zheng NY, et al: p38 kinase is activated in the Alzheimer's disease brain. J Neurochem 1999; 72:2053-2058
162. Reynolds CH, Nebreda AR, Gibb GM, et al: Reactivating kinase/p38 phosphorylates tau protein in vitro. J Neurochem 1997; 69: 191-198
163. McDonald DR, Bamberger ME, Combs CK, et al: Beta-amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 1998; 18:4451-4460
164. Lim M, Martinez T, Jablons D, et al: Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett 1998; 441:88-92
165. Westermarck J, Holmstrom T, Ahonen M, et al: Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol 1998; 17:547-557
166. Ravanti L, Heino J, Lopez-Otin C, et al: Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem 1999; 274:2446-2455
167. Funato N, Moriyama K, Saitoh M, et al: Evidence for apoptosis signal-regulating kinase 1 in the regenerating palatal epithelium upon acute injury. Lab Invest 1998; 78:477-483
168. Aoshiba K, Yasui S, Nishimura K, et al: Thiol depletion induces apoptosis in cultured lung fibroblasts. Am J Respir Cell Mol Biol 1999; 21:54-64
169. Badger AM, Bradbeer JN, Votta B, et al: Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 1996; 279:1453-1461
170. Jackson JR, Bolognese B, Hillegass L, et al: Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther 1998; 284:687-692
171. Carter AB, Monick MM, Hunninghake GW: Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 1999; 20:751-758
172. Ogura M, Kitamura M: Oxidant stress incites spreading of macrophages via extracellular signal-regulated kinases and p38 mitogen-activated protein kinase. J Immunol 1998; 161:3569-3574
173. Whitmarsh AJ, Davis RJ: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996; 74:589-607
174. Larrivee JF, Bachvarov DR, Houle F, et al: Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury. J Immunol 1998; 160:1419-1426